SCHEDULE APPOINTMENT: CALL 800.999.1249 OR SCHEDULE ONLINE
AstraZeneca (Anchor) Asthma Study
Recruitment for this study has concluded. We thank all participants for their interest and contributions to asthma research.
For questions about future studies, please contact our research staff at 502.368.0732
Explore More About These Research Trials
An easy way to track when your study milestones, treatments, or updates are expected.
- Home >
- About >
- Research Institute >
- Current Research Studies >
- AstraZeneca (Anchor) Asthma Study
ASTRAZENECA (ANCHOR) ADULTS AGED 18 AND ABOVE {ASTHMA STUDY}
- Recruitment for this study has concluded. We thank all participants for their interest and contributions to asthma research. For questions about future studies, please contact our research staff at 502.368.0732.
- The product being studied, AIRSUPRA (albuterol and budesonide) inhalation aerosol for oral inhalation use.
- The purpose of the study: Assessment of Combination Short-Acting Bronchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care”
- Study duration: participants are expected to take part in this study for approximately twelve (12) months.
Key Inclusion Criteria:
- At least 1 diagnosis of asthma prior to the enrollment date documented in patient record
- At least 1 severe asthma exacerbation within 12 months before enrollment date.
- At least 1 prescription filled for SABA-only inhaler (i.e., albuterol-only or levalbuterol-only inhalers) within 12 months before enrollment date.
Key Exclusion Criteria:
- Conditions with major respiratory diagnoses including COPD.
- Chronic use of oral corticosteroids (for any condition) within 3 months before enrollment date.
- History of AIRSUPRA use within 12 months before enrollment date.
Interested in hearing more about these Research Trials?
Please contact one of our staff at 502.368.0732 or fill out the form below: